15/04/2026
⚠️NEW gene therapy study for FTD starting at ECRU‼️
For families impacted by genetic Frontotemporal Dementia (FTD), the journey can be incredibly challenging — especially knowing it can be passed from one generation to the next.
We are excited to be recruiting for a new gene therapy study by Passage Bio, involving individuals with genetic FTD due to GRN or C9orf72 mutations. Share this with anyone who might benefit, and contact us with any questions 🧬
Interested in learning more about a potential new therapy called PBFT02 for the treatment of frontotemporal dementia caused by a GRN mutation?
We are here to help, and we're happy to answer any questions you may have about FTD, the treatment we are studying, and the clinical trial: https://passagebioclinicaltrials.com/Frontotemporal-Dementia/